Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Immune response to recombinant Burkholderia pseudomallei FliC.

Koosakulnirand S, Phokrai P, Jenjaroen K, Roberts RA, Utaisincharoen P, Dunachie SJ, Brett PJ, Burtnick MN, Chantratita N.

PLoS One. 2018 Jun 14;13(6):e0198906. doi: 10.1371/journal.pone.0198906. eCollection 2018.

2.

A Rapid Immunochromatography Test Based on Hcp1 Is a Potential Point-of-Care Test for Serological Diagnosis of Melioidosis.

Phokrai P, Karoonboonyanan W, Thanapattarapairoj N, Promkong C, Dulsuk A, Koosakulnirand S, Canovali S, Indrawattana N, Jutrakul Y, Wuthiekanun V, Limmathurotsakul D, Brett PJ, Burtnick MN, Lertmemongkolchai G, Chantratita N.

J Clin Microbiol. 2018 Jul 26;56(8). pii: e00346-18. doi: 10.1128/JCM.00346-18. Print 2018 Aug.

3.

Use of Rapid Enzyme-Linked Immunosorbent Assays for Serological Screening of Melioidosis in Myanmar.

Win ZZ, Phokrai P, Aung Z, Zaw T, Burtnick MN, Chantratita N, Brett PJ, Hlaing TM.

Am J Trop Med Hyg. 2018 May;98(5):1300-1302. doi: 10.4269/ajtmh.17-0791. Epub 2018 Mar 15.

4.

Retrospective Analysis of Fever and Sepsis Patients from Cambodia Reveals Serological Evidence of Melioidosis.

Suttisunhakul V, Hip P, Ouch P, Ly P, Supaprom C, Rachmat A, Prouty M, Vaughn A, Eltayeb A, Kheng S, Clark DV, Lawler JV, Chantratita N, Burtnick MN, Brett PJ, Schully KL.

Am J Trop Med Hyg. 2018 Apr;98(4):1039-1045. doi: 10.4269/ajtmh.17-0885. Epub 2018 Feb 8.

5.

Development of Subunit Vaccines That Provide High-Level Protection and Sterilizing Immunity against Acute Inhalational Melioidosis.

Burtnick MN, Shaffer TL, Ross BN, Muruato LA, Sbrana E, DeShazer D, Torres AG, Brett PJ.

Infect Immun. 2017 Dec 19;86(1). pii: e00724-17. doi: 10.1128/IAI.00724-17. Print 2018 Jan.

6.

Deciphering minimal antigenic epitopes associated with Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharide O-antigens.

Tamigney Kenfack M, Mazur M, Nualnoi T, Shaffer TL, Ngassimou A, Blériot Y, Marrot J, Marchetti R, Sintiprungrat K, Chantratita N, Silipo A, Molinaro A, AuCoin DP, Burtnick MN, Brett PJ, Gauthier C.

Nat Commun. 2017 Jul 24;8(1):115. doi: 10.1038/s41467-017-00173-8.

7.

Genome-scale analysis of the genes that contribute to Burkholderia pseudomallei biofilm formation identifies a crucial exopolysaccharide biosynthesis gene cluster.

Borlee GI, Plumley BA, Martin KH, Somprasong N, Mangalea MR, Islam MN, Burtnick MN, Brett PJ, Steinmetz I, AuCoin DP, Belisle JT, Crick DC, Schweizer HP, Borlee BR.

PLoS Negl Trop Dis. 2017 Jun 28;11(6):e0005689. doi: 10.1371/journal.pntd.0005689. eCollection 2017 Jun.

8.

A nonsense mutation in TLR5 is associated with survival and reduced IL-10 and TNF-α levels in human melioidosis.

Chaichana P, Chantratita N, Brod F, Koosakulnirand S, Jenjaroen K, Chumseng S, Sumonwiriya M, Burtnick MN, Brett PJ, Teparrukkul P, Limmathurotsakul D, Day NPJ, Dunachie SJ, West TE.

PLoS Negl Trop Dis. 2017 May 5;11(5):e0005587. doi: 10.1371/journal.pntd.0005587. eCollection 2017 May.

9.

Comparison of O-polysaccharide and hemolysin co-regulated protein as target antigens for serodiagnosis of melioidosis.

Pumpuang A, Dunachie SJ, Phokrai P, Jenjaroen K, Sintiprungrat K, Boonsilp S, Brett PJ, Burtnick MN, Chantratita N.

PLoS Negl Trop Dis. 2017 Mar 30;11(3):e0005499. doi: 10.1371/journal.pntd.0005499. eCollection 2017 Mar.

10.

Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?

Titball RW, Burtnick MN, Bancroft GJ, Brett P.

Vaccine. 2017 Oct 20;35(44):5981-5989. doi: 10.1016/j.vaccine.2017.03.022. Epub 2017 Mar 21. Review.

11.

Development of Immunoassays for Burkholderia pseudomallei Typical and Atypical Lipopolysaccharide Strain Typing.

Nualnoi T, Norris MH, Tuanyok A, Brett PJ, Burtnick MN, Keim PS, Settles EW, Allender CJ, AuCoin DP.

Am J Trop Med Hyg. 2017 Feb 8;96(2):358-367. doi: 10.4269/ajtmh.16-0308. Epub 2016 Dec 19.

12.

Thermoregulation of Biofilm Formation in Burkholderia pseudomallei Is Disrupted by Mutation of a Putative Diguanylate Cyclase.

Plumley BA, Martin KH, Borlee GI, Marlenee NL, Burtnick MN, Brett PJ, AuCoin DP, Bowen RA, Schweizer HP, Borlee BR.

J Bacteriol. 2017 Feb 14;199(5). pii: e00780-16. doi: 10.1128/JB.00780-16. Print 2017 Mar 1.

13.

In vivo Distribution and Clearance of Purified Capsular Polysaccharide from Burkholderia pseudomallei in a Murine Model.

Nualnoi T, Kirosingh A, Pandit SG, Thorkildson P, Brett PJ, Burtnick MN, AuCoin DP.

PLoS Negl Trop Dis. 2016 Dec 12;10(12):e0005217. doi: 10.1371/journal.pntd.0005217. eCollection 2016 Dec.

14.

pH Alkalinization by Chloroquine Suppresses Pathogenic Burkholderia Type 6 Secretion System 1 and Multinucleated Giant Cells.

Chua J, Senft JL, Lockett SJ, Brett PJ, Burtnick MN, DeShazer D, Friedlander AM.

Infect Immun. 2016 Dec 29;85(1). pii: e00586-16. doi: 10.1128/IAI.00586-16. Print 2017 Jan.

15.

Contribution of murine IgG Fc regions to antibody binding to the capsule of Burkholderia pseudomallei.

Dillon MJ, Loban RA, Reed DE, Thorkildson P, Pflughoeft KJ, Pandit SG, Brett PJ, Burtnick MN, AuCoin DP.

Virulence. 2016 Aug 17;7(6):691-701. doi: 10.1080/21505594.2016.1176655. Epub 2016 Apr 20.

16.

Development of Rapid Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Burkholderia pseudomallei.

Suttisunhakul V, Wuthiekanun V, Brett PJ, Khusmith S, Day NP, Burtnick MN, Limmathurotsakul D, Chantratita N.

J Clin Microbiol. 2016 May;54(5):1259-68. doi: 10.1128/JCM.02856-15. Epub 2016 Feb 24.

17.

Burkholderia pseudomallei Capsular Polysaccharide Recognition by a Monoclonal Antibody Reveals Key Details toward a Biodefense Vaccine and Diagnostics against Melioidosis.

Marchetti R, Dillon MJ, Burtnick MN, Hubbard MA, Kenfack MT, Blériot Y, Gauthier C, Brett PJ, AuCoin DP, Lanzetta R, Silipo A, Molinaro A.

ACS Chem Biol. 2015 Oct 16;10(10):2295-302. doi: 10.1021/acschembio.5b00502. Epub 2015 Aug 5.

PMID:
26198038
18.

Evaluation of Polysaccharide-Based Latex Agglutination Assays for the Rapid Detection of Antibodies to Burkholderia pseudomallei.

Suttisunhakul V, Chantratita N, Wikraiphat C, Wuthiekanun V, Douglas Z, Day NPJ, Limmathurotsakul D, Brett PJ, Burtnick MN.

Am J Trop Med Hyg. 2015 Sep;93(3):542-546. doi: 10.4269/ajtmh.15-0114. Epub 2015 Jun 29.

19.

Colony morphology variation of Burkholderia pseudomallei is associated with antigenic variation and O-polysaccharide modification.

Wikraiphat C, Saiprom N, Tandhavanant S, Heiss C, Azadi P, Wongsuvan G, Tuanyok A, Holden MT, Burtnick MN, Brett PJ, Peacock SJ, Chantratita N.

Infect Immun. 2015 May;83(5):2127-38. doi: 10.1128/IAI.02785-14. Epub 2015 Mar 16.

20.

Melioidosis: molecular aspects of pathogenesis.

Stone JK, DeShazer D, Brett PJ, Burtnick MN.

Expert Rev Anti Infect Ther. 2014 Dec;12(12):1487-99. doi: 10.1586/14787210.2014.970634. Epub 2014 Oct 14. Review.

21.

Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis.

Scott AE, Burtnick MN, Stokes MG, Whelan AO, Williamson ED, Atkins TP, Prior JL, Brett PJ.

Infect Immun. 2014 Aug;82(8):3206-13. doi: 10.1128/IAI.01847-14. Epub 2014 May 27.

22.

Proteomic analysis of the Burkholderia pseudomallei type II secretome reveals hydrolytic enzymes, novel proteins, and the deubiquitinase TssM.

Burtnick MN, Brett PJ, DeShazer D.

Infect Immun. 2014 Aug;82(8):3214-26. doi: 10.1128/IAI.01739-14. Epub 2014 May 27.

23.

Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis.

Houghton RL, Reed DE, Hubbard MA, Dillon MJ, Chen H, Currie BJ, Mayo M, Sarovich DS, Theobald V, Limmathurotsakul D, Wongsuvan G, Chantratita N, Peacock SJ, Hoffmaster AR, Duval B, Brett PJ, Burtnick MN, Aucoin DP.

PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2727. doi: 10.1371/journal.pntd.0002727. eCollection 2014 Mar.

24.

Burkholderia mallei and Burkholderia pseudomallei cluster 1 type VI secretion system gene expression is negatively regulated by iron and zinc.

Burtnick MN, Brett PJ.

PLoS One. 2013 Oct 11;8(10):e76767. doi: 10.1371/journal.pone.0076767. eCollection 2013.

25.

Revised structures for the predominant O-polysaccharides expressed by Burkholderia pseudomallei and Burkholderia mallei.

Heiss C, Burtnick MN, Roberts RA, Black I, Azadi P, Brett PJ.

Carbohydr Res. 2013 Nov 15;381:6-11. doi: 10.1016/j.carres.2013.08.013. Epub 2013 Aug 24.

26.

Development of novel O-polysaccharide based glycoconjugates for immunization against glanders.

Burtnick MN, Heiss C, Schuler AM, Azadi P, Brett PJ.

Front Cell Infect Microbiol. 2012 Nov 27;2:148. doi: 10.3389/fcimb.2012.00148. eCollection 2012.

27.

Detailed structural analysis of the O-polysaccharide expressed by Burkholderia thailandensis E264.

Heiss C, Burtnick MN, Black I, Azadi P, Brett PJ.

Carbohydr Res. 2012 Dec 1;363:23-8. doi: 10.1016/j.carres.2012.09.027. Epub 2012 Oct 11.

28.

Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.

Burtnick MN, Heiss C, Roberts RA, Schweizer HP, Azadi P, Brett PJ.

Front Cell Infect Microbiol. 2012 Aug 15;2:108. doi: 10.3389/fcimb.2012.00108. eCollection 2012.

29.

Structural analysis of capsular polysaccharides expressed by Burkholderia mallei and Burkholderia pseudomallei.

Heiss C, Burtnick MN, Wang Z, Azadi P, Brett PJ.

Carbohydr Res. 2012 Feb 15;349:90-4. doi: 10.1016/j.carres.2011.12.011. Epub 2011 Dec 23.

PMID:
22221792
30.

Identification of circulating bacterial antigens by in vivo microbial antigen discovery.

Nuti DE, Crump RB, Dwi Handayani F, Chantratita N, Peacock SJ, Bowen R, Felgner PL, Davies DH, Wu T, Lyons CR, Brett PJ, Burtnick MN, Kozel TR, AuCoin DP.

MBio. 2011 Aug 16;2(4). pii: e00136-11. doi: 10.1128/mBio.00136-11. Print 2011.

31.

The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei.

Burtnick MN, Brett PJ, Harding SV, Ngugi SA, Ribot WJ, Chantratita N, Scorpio A, Milne TS, Dean RE, Fritz DL, Peacock SJ, Prior JL, Atkins TP, Deshazer D.

Infect Immun. 2011 Apr;79(4):1512-25. doi: 10.1128/IAI.01218-10. Epub 2011 Feb 7.

32.

Burkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-like O polysaccharides.

Brett PJ, Burtnick MN, Heiss C, Azadi P, DeShazer D, Woods DE, Gherardini FC.

Infect Immun. 2011 Feb;79(2):961-9. doi: 10.1128/IAI.01023-10. Epub 2010 Nov 29.

33.

Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages.

Burtnick MN, DeShazer D, Nair V, Gherardini FC, Brett PJ.

Infect Immun. 2010 Jan;78(1):88-99. doi: 10.1128/IAI.00985-09. Epub 2009 Nov 2.

34.

Burkholderia mallei tssM encodes a putative deubiquitinase that is secreted and expressed inside infected RAW 264.7 murine macrophages.

Shanks J, Burtnick MN, Brett PJ, Waag DM, Spurgers KB, Ribot WJ, Schell MA, Panchal RG, Gherardini FC, Wilkinson KD, Deshazer D.

Infect Immun. 2009 Apr;77(4):1636-48. doi: 10.1128/IAI.01339-08. Epub 2009 Jan 21.

35.

Treponema denticola TroR is a manganese- and iron-dependent transcriptional repressor.

Brett PJ, Burtnick MN, Fenno JC, Gherardini FC.

Mol Microbiol. 2008 Oct;70(2):396-409. doi: 10.1111/j.1365-2958.2008.06418.x. Epub 2008 Aug 27.

36.

Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages.

Burtnick MN, Brett PJ, Nair V, Warawa JM, Woods DE, Gherardini FC.

Infect Immun. 2008 Jul;76(7):2991-3000. doi: 10.1128/IAI.00263-08. Epub 2008 Apr 28.

37.

iNOS activity is critical for the clearance of Burkholderia mallei from infected RAW 264.7 murine macrophages.

Brett PJ, Burtnick MN, Su H, Nair V, Gherardini FC.

Cell Microbiol. 2008 Feb;10(2):487-98. Epub 2007 Oct 28.

38.

Genetic basis for retention of a critical virulence plasmid of Borrelia burgdorferi.

Jewett MW, Byram R, Bestor A, Tilly K, Lawrence K, Burtnick MN, Gherardini F, Rosa PA.

Mol Microbiol. 2007 Nov;66(4):975-90. Epub 2007 Oct 4.

39.

Insights into the complex regulation of rpoS in Borrelia burgdorferi.

Burtnick MN, Downey JS, Brett PJ, Boylan JA, Frye JG, Hoover TR, Gherardini FC.

Mol Microbiol. 2007 Jul;65(2):277-93. Epub 2007 Jun 21.

40.

Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes.

Brett PJ, Burtnick MN, Snyder DS, Shannon JG, Azadi P, Gherardini FC.

Mol Microbiol. 2007 Jan;63(2):379-90. Epub 2006 Dec 5.

41.

An extracellular zinc metalloprotease gene of Burkholderia cepacia.

Corbett CR, Burtnick MN, Kooi C, Woods DE, Sokol PA.

Microbiology. 2003 Aug;149(Pt 8):2263-71.

PMID:
12904566
42.
43.

Identification of genes encoding secreted proteins using mini-OphoA mutagenesis.

Burtnick MN, Brett PJ, Woods DE.

Methods Mol Biol. 2003;205:329-38. No abstract available.

PMID:
12491898
44.

Molecular and physical characterization of Burkholderia mallei O antigens.

Burtnick MN, Brett PJ, Woods DE.

J Bacteriol. 2002 Feb;184(3):849-52.

45.

Current studies on the pathogenesis of melioidosis.

Woods DE, DeShazer D, Moore RA, Brett PJ, Burtnick MN, Reckseidler SL, Senkiw MD.

Microbes Infect. 1999 Feb;1(2):157-62. Review.

PMID:
10594980
47.

Molecular characterization of genetic loci required for secretion of exoproducts in Burkholderia pseudomallei.

DeShazer D, Brett PJ, Burtnick MN, Woods DE.

J Bacteriol. 1999 Aug;181(15):4661-4.

Supplemental Content

Loading ...
Support Center